Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance
10/28/2026
Impact: 70
Healthcare
Labcorp reported third-quarter 2026 revenue of $3.81 billion, up 7% year over year and above the $3.76 billion FactSet estimate. Adjusted EPS rose 14.5% to $4.78, beating the $4.64 estimate, with growth attributed to margin expansion and operating leverage. The company raised its 2026 guidance to adjusted EPS of $18.30–$18.70 and revenue of $14.78–$14.89 billion. Labcorp also reported $255.5 million in acquisitions during the quarter and declared a quarterly dividend of $0.72 per share.
AI summary, not financial advice
Share: